What is the TASMINH4 trial?

This research is a patient randomised controlled trial to evaluate the management of hypertension in primary care using self monitored blood pressure values, with or without tele-monitoring, compared to that using clinic monitored blood pressure. It will also consider the effect of self-monitoring and tele-monitoring on adherence, side effects, quality of life, adverse events and costs. This study is being run by the Universities of Birmingham and Oxford underpinning key work from previous blood pressure surveys and TASMINH trials (TASMINH, TASMINH2, TASMIN-SR).

WE ARE LOOKING TO RECRUIT APPROXIMATELY 110 PRACTICES NATIONALLY FROM NOW UNTIL AUGUST 2015

What is involved for Practices?

· Practices will identify potential participants (patients with coded hypertension with a BP ≥140 (systolic) and/or 90 (diastolic) mmHg)

· Room hire for holding baseline and follow-up clinics (6 and 12 months)

· Mail study invitation letters to trial participants

Full training will be provided

Practices undertaking this study will be eligible to receive payment via service support costs to cover the time spent recruiting patients.

Learn More

If your practice would like to take part or would like more information please contact: Mrs Siobhan Milner, Project Officer tel: 0121 414 2954, fax: 0121 414 8616, email: s.l.milner@bham.ac.uk